Novo Nordisk (NVON) Q4 2024 Earnings Report
MX:NVON Q4 2024 EPS Results
- Actual EPS
- MXN 16.46
- Consensus EPS
- MXN 15.44
- Beat/Miss
- Beat by +MXN 1.02
- One Year Ago EPS
- MXN 13.30
MX:NVON Q4 2024 Revenue Results
- Actual Revenue
- MXN 227.68B
- Expected Revenue
- MXN 206.91B
- Beat/Miss
- Beat by +MXN 20.77B
- YoY Revenue Growth
- +29.05%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/05/2025
- Time
- Before Open
- Conference Call
- Wednesday, February 5, 2025
MX:NVON Upcoming Earnings
Novo Nordisk's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
MX:NVON Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVON Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 13.58- | 12.86 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | 14.3117.74 | 17.26 | 2.80% (+0.48) | |
| May 06, 2026 | 2026 (Q1) | 16.4319.38 | 18.49 | 4.82% (+0.89) | |
| Feb 04, 2026 | 2025 (Q4) | 17.1517.73 | 16.46 | 7.67% (+1.26) | |
| Nov 05, 2025 | 2025 (Q3) | 14.2012.86 | 16.37 | -21.45% (-3.51) | |
| Aug 06, 2025 | 2025 (Q2) | 17.0817.26 | 12.23 | 41.19% (+5.04) | |
| May 07, 2025 | 2025 (Q1) | 17.0018.49 | 15.12 | 22.24% (+3.36) | |
| Feb 05, 2025 | 2024 (Q4) | 15.4416.46 | 13.3 | 23.74% (+3.16) | |
| Nov 06, 2024 | 2024 (Q3) | 16.3516.37 | 13.21 | 23.91% (+3.16) | |
| Aug 07, 2024 | 2024 (Q2) | 13.1612.23 | 11.85 | 3.13% (+0.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
